Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Photodynamic Therapy Using HPPH for Obstructive Esophageal Tumors
NCT00060268Phase 2Completed
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- Jan 1997
- Primary completion
- Sep 2003
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
Phase 2, open-label trial of hpph in esophageal cancer (2 arms), sponsored by Roswell Park Comprehensive Cancer Center. Primary endpoints: Safety of HPPH, Tumor Response and 2 more. Started Jan 1997; status: completed.
02
Drugs
hpph
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT00060268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00060268.